Centinel Spine gets FDA nod for two-level use of prodisc C Nova

Centinel Spine received FDA approval to expand ProDisc C Nova, its cervical total disc replacement system, for two-level use. The expansion permits the device to treat degenerative disc disease across two adjacent vertebral levels in the cervical spine, broadening its clinical application from prior single-level clearance.